Summary:
The purpose of this study is to understand the safety of the study vaccine which is the fourth-generation pneumococcal conjugate vaccine with adjuvant (PG4 vaccine). An adjuvant is a substance added to a vaccine that helps it work better. PG4 may provide additional protection against pneumococcal disease beyond Prevnar 20 and may make an improvement in the immune response (i.e., the number of antibodies made) that the vaccine generates.
Qualified Participants Must:
• Must be 65 years or older
•
Must have never received a pneumonia vaccine or received their last pneumonia vaccine more than 5 years ago
Qualified Participants May Receive:
No cost pneumonia vaccine
Compensation for time and travel could be available if qualified
No insurance required